L24_Treatment for Gingival Enlargementedit
-
Upload
hegar-s-pribadi -
Category
Documents
-
view
219 -
download
0
Transcript of L24_Treatment for Gingival Enlargementedit
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
1/29
Treatment of Gingival Enlargement
Rikko Hudyono
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
2/29
Treatment Choices
is based on an understanding of the cause and
underlying pathologic changes.
Gingival enlargements are of special concern to the
patient and dentist because they pose problems in
plaque control, function (including mastication,
tooth eruption, and speech), and esthetics.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
3/29
Chronic Inflammatory Enlargements
Edematous
Fibrous
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
4/29
Chronic Inflammatory Enlargements
Chronic inflammatory enlargements are soft and
discolored and are caused principally by edema and
cellular infiltration.
These gingival enlargements are treated by scaling
and root planing.
The size will be shrink after complete removal ofthe deposits.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
5/29
Chronic Inflammatory Enlargements
How surgical approaches are needed?
Fibrotic component that does not undergo
shrinkage after scaling and root planing
Obscure deposits on the tooth surfaces andinterfere with access to them
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
6/29
Chronic Inflammatory Enlargements
Selection of the appropriate technique depends on the size of
the enlargement and character of the tissue.
When the enlarged gingiva remains soft and friable even
after scaling and root planing, a gingivectomyis used to
remove it because a flap requires a firmer tissue to perform
the incisions and other steps in the technique.
However, if the gingivectomy incision removes all of the
attached, keratinized gingiva, which will create a
mucogingival problem, then theflap techniqueis
indicated.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
7/29
Drug-Associated Gingival Enlargement
Anticonvulsants
Calcium channel blockers
Immunosuppressant
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
8/29
Drug-Associated Gingival Enlargement
Usually be in combination
Fibrotic components induced by the drugs
Inflammatory components caused by the bacterialplaque
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
9/29
Treatment Options
First,consideration should be given to the possibility ofdiscontinuing the drug or changing the medication
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
10/29
Phenytoin to be Carbamazepine or Valproate
Nifedipine to be Diltiazem or verapamil. And
consider to use another class of antihypertensive
medication
Cyclosporine to be Tacrolimus
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
11/29
Treatment Options
Second,the clinician should emphasize plaque control asthe first step in the treatment of drug-induced gingival
enlargement.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
12/29
Treatment Options
Third,in some patients, gingival enlargement persistseven after careful consideration of the previous approaches.
These patients may require surgery, either gingivectomy or
the periodontal flap.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
13/29
Gingivectomy
Advantage
simple and quick
Disadvantages
postoperative discomfort
increased chance of postoperative bleeding
Sacrifice keratinized tissue
Doesnt allow osseous reconstruction
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
14/29
Gingivectomy
Consider
the extent of the area to be operated
the presence of periodontitis and osseous defects
the location of the base of the pockets in relation tothe mucogingival junction.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
15/29
Gingivectomy
External bevel cut
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
16/29
Gingivectomy
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
17/29
Treatment protocol
Patient taking drug
known to cause
gingival enlargement
Phase I Therapy
Maintenance
Gingival
enlargement
Re-evaluation
Phase II Therapy
Periodontal flapGingivectomy
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
18/29
Periodontal Flap
Indications:
Larger areas of gingival enlargement (more than six
teeth)
Areas where attachment loss and osseous defects
are present
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
19/29
After anesthetizing the area, sounding of the underlying alveolar bone is
performed with a periodontal probe to determine the presence and extent of
osseous defects.
With a #15 Bard-Parker blade, the initial scalloped internal bevel incision is made
at least 3 mm coronal to the mucogingival junction, including the creation of newinterdental papillae.
The same blade is used to thin the gingival tissues in a buccolingual direction to
the mucogingival junction. At this point the blade establishes contact with the
alveolar bone, and a full-thickness or a split-thickness flap is elevated.
Using an Orban knife, the base of each papilla connecting the facial and the
lingual incisions is incised. The excised marginal and interdental tissues are removed with curettes.
Tissue tabs are removed, the roots are thoroughly scaled and planed, and the
bone is recontoured as needed.
The flap is replaced and if necessary, trimmed to reach the bone-tooth junction.
The flap is then sutured with an interrupted or a continuous mattress technique.
The surgical area is covered with a periodontal dressing.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
20/29
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
21/29
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
22/29
Leukemic Gingival Enlargement
Leukemic enlargement occurs in acute or subacuteleukemia.
The medical care of leukemic patients is oftencomplicated by gingival enlargement andsuperimposed painful acute necrotizing ulcerativegingivitis.
The patient's bleeding and clotting times andplatelet count should be checked, and thehematologist should be consulted beforeperiodontal treatment is instituted
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
23/29
Treatments
Scaling and root planing with topical and local
anesthesia.
Chlorhexidine mouthwashes. Oral hygiene procedures are extremely important
Progressively deeper scaling is carried out at
subsequent visits.
Antibiotics are administered systemically the
evening before and for 48 hours after each
treatment to reduce the risk of infection.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
24/29
Gingival Enlargement in Pregnancy
Treatment requires elimination of all local irritants
responsible for precipitating the gingival changes in
pregnancy.
Elimination of local irritants early in pregnancy is a
preventive measure against gingival disease.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
25/29
Treatment of tumorlike gingival enlargements
consists of surgical excision and scaling and planing
of the tooth surface.
The enlargement will recur unless all of the irritants
are removed. Food impaction is frequently an
inciting factor.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
26/29
Gingival Enlargement in Puberty
Gingival enlargement in puberty is treated by
performing scaling and curettage, removing all
sources of irritation, and controlling plaque.
Surgical removal may be required in severe cases.
The problem in these patients is recurrence that
results from poor oral hygiene.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
27/29
Recurrence
Recurrence after treatment is the most common
problem in the management of gingival
enlargement.
Residual local irritation and systemic or hereditary
conditions causing noninflammatory gingival
hyperplasia are the responsible factors.
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
28/29
Recurrence
Food impaction
Overhanging margins of restorations
Inadequate plaque control by the patient
-
8/12/2019 L24_Treatment for Gingival Enlargementedit
29/29
Recurrence
Familial, hereditary, or idiopathic gingival
enlargement recurs after surgical removal even
after all local irritants have been removed. The
enlargement can be maintained at minimal size by
preventing secondary inflammatory involvement.